Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Stephen Bagley, Meghan Logun, Joseph A. Fraietta, Xin Wang, Arati Desai, Linda J. Bagley, Ali Nabavizadeh, Danuta Jarocha, Rene Martins, Eileen Maloney, Lester Lledo, Carly Stein, Amy Marshall, Rachel Leskowitz, Julie K. Jadlowsky, Shannon Christensen, Bike Su Oner, Gabriela Plesa, Andrea Brennan, Vanessa Gonzalez, Fang Chen, Yusha Sun, Whitney L. Gladney, David M. Barrett, MacLean P. Nasrallah, Wei‐Ting Hwang, Guo‐li Ming, Hongjun Song, Donald L. Siegel, Carl H. June, Elizabeth O. Hexner, Zev A. Binder, Donald M. O’Rourke
Topics & Concepts
InterimIntrathecalMedicineGlioblastomaBivalent (engine)OncologyPharmacologyCancer researchInternal medicineChemistrySurgeryHistoryOrganic chemistryArchaeologyMetalCAR-T cell therapy researchNanowire Synthesis and ApplicationsNanofabrication and Lithography Techniques